dc.contributor.author |
Tyagi, Vikas |
|
dc.contributor.author |
Khan, Shahnawaz |
|
dc.contributor.author |
Shivahare, Rahul |
|
dc.contributor.author |
Srivastava, Khushboo |
|
dc.contributor.author |
Gupta, Suman |
|
dc.contributor.author |
Kidwai, Saqib |
|
dc.contributor.author |
Srivastava, Kumkum |
|
dc.contributor.author |
Puri, S K |
|
dc.contributor.author |
Chauhan, P M S |
|
dc.date.accessioned |
2013-02-05T10:24:14Z |
|
dc.date.available |
2013-02-05T10:24:14Z |
|
dc.date.issued |
2013 |
|
dc.identifier.citation |
Bioorganic & Medicinal Chemistry Letters 2013, 23(1), 291–296 |
en |
dc.identifier.uri |
http://hdl.handle.net/123456789/996 |
|
dc.description.abstract |
A natural product inspired molecular hybridization approach led us to a series of novel pentamidine based pyrimidine and chalcone scaffolds. All the hybrids were evaluated for their anti-leishmanial potential. Most of the screened compounds have showed significant in vitro anti-leishmanial activity with less cytotoxicity in comparison to the standard drugs (pentamidine, sodium stibogluconate, and miltefosine). Additionally, anti-malarial screening of these compounds was also done and four compounds have shown superior activity against chloroquine resistance strain (K1) of Plasmodium falciparum. |
en |
dc.format.extent |
785252 bytes |
|
dc.format.mimetype |
application/pdf |
|
dc.language.iso |
en |
en |
dc.relation.ispartofseries |
CDRI Communication No. 8343 |
en |
dc.subject |
Pyrimidine |
en |
dc.subject |
Chalcone |
en |
dc.subject |
Pentamidine |
en |
dc.subject |
Anti-leishmanial activity |
en |
dc.subject |
Anti-malarial activity |
en |
dc.title |
A natural product inspired hybrid approach towards the synthesis of novel pentamidine based scaffolds as potential anti-parasitic agents |
en |
dc.type |
Article |
en |